Home/ Stocks/ LLY

Eli Lilly & Co.

LLY XNYS

$1009.52 +30.46 (+3.02%) ▲ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$952.34B

About Eli Lilly & Co.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 50.0K Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$65.18B	$20.64B	$23.00
FY 2025	$65.18B	$20.64B	$23.00
Q3 2025	$17.60B	$5.58B	$6.22
Q2 2025	$15.56B	$5.66B	$6.30

Ticker Daily Articles on LLY

How to Trade Gaps: Gap Up, Gap Down, and Gap Fill Strategies

Alex Chen · 5h ago · News

Get LLY Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Eli Lilly & Co..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.